Renalytix secures $29.1 million in funding to support the development and commercialization of two product categories for the early detection of kidney disease and accurate management of kidney transplant rejection
By Elise Wilfinger|2023-01-23T16:15:22+00:0001.18.23|Comments Off on 4Q: 2018